iNtRON Biotechnology Market Cap

iNtRON Biotechnology has a market cap or net worth of 106.7 billion as of October 31, 2025. Its market cap has decreased by -42.99% in one year.

Market Cap

106.70B

Enterprise Value

66.36B

Revenue

5.14B

Ranking

n/a

PE Ratio

n/a

Stock Price

3,320.00

Market Cap Chart

Since January 26, 2011, iNtRON Biotechnology's market cap has increased from 95.30B to 106.70B, an increase of 11.96%. That is a compound annual growth rate of 0.77%.

Market Cap History

Date	Market Cap	% Change
Oct 31, 2025	104.96B	-42.82%
Dec 30, 2024	183.56B	-37.01%
Dec 28, 2023	291.42B	7.98%
Dec 29, 2022	269.88B	-61.99%
Dec 30, 2021	710.00B	-22.41%
Dec 30, 2020	915.06B	97.15%
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro
Dec 30, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	87.69T
Celltrion	39.50T
ALTEOGEN	25.46T
SK Biopharmaceuticals	9.08T
Yuhan	8.94T
HLB Co., Ltd.	6.25T
Peptron	6.06T
PharmaResearch	5.57T

Market Cap Rankings